Personalized Medicine in Otolaryngology: Special Topic Otology—2nd Edition

Dear Colleagues,

In collaboration with the Journal of Personalized Medicine (IF: 3.4), in my capacity as Guest Editor, I am helping to organize a Special Issue entitled “Personalized Medicine in Otolaryngology: Special Topic Otology—2nd Edition”. Globally, more than 1.5 billion people experience some degree of hearing loss. Of these, an estimated 432 million adults and 34 million children suffer from disabling hearing loss, that is, hearing loss of moderate or high severity in the better hearing ear (WHO World Report on Hearing, 2021). Disabling hearing loss and a lack of benefit from conventional hearing aids are essential indications for the use of implantable hearing systems. The type of hearing implant to be used is dictated by the hearing threshold, the underlying pathology, and the anatomical conditions of the patient.

This Special Issue on otology aims to give a broad overview of personalized hearing rehabilitation across all ages and indications (very young children, adults, and very old adults), different applications, as well as necessary rehabilitation options. The title is kept broad to cover all aspects of personalized treatment options and their positive impact on a patient’s quality of life, from auditory brainstem implants to cochlear implants, bone conduction implants, and middle-ear implants.

In the past several decades, the technology behind all the above-mentioned hearing implants has developed immensely. This Special Issue on otology aims to discuss and broadcast some of these recent achievements and even provide a perspective on future developments in hearing technology.

Prof. Dr. Georg Mathias Sprinzl
Dr. Astrid Magele
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.